期刊文献+

血浆MMPs活性检测对甲状腺乳头状癌患者的临床意义 被引量:4

Change and significance of the serous activity of matrix metalloproteinases in patients with papillary thyroid carcinoma
下载PDF
导出
摘要 目的本研究观察血浆基质金属蛋白酶MMP-2和MMP-9活性与甲状腺乳头状癌侵袭和转移的关系,以探讨其临床意义。方法本院1999年-2003年共有明确病理结果、无基础疾病史并经检查排除相关疾病的甲状腺乳头状癌患者74例,所有患者行甲状腺癌改良根治术(肿瘤侧腺叶全切加夹部切除加对侧次全切,颈部淋巴结清扫),术后依照病理结果分组,并用明胶酶谱法测定患者血浆MMP-2和MMP-9活性。检测结果采用SPSS10.0forwindows软件包进行t检验。结果淋巴结转移组的血浆MMP-2(62KD)和MMP-9(82KD)活性(71.93±11.72、15.50±6.06)明显高于无淋巴结转移组(35.16±6.63、7.27±2.30)(P<0.001);包膜及包膜外浸润组的血浆MMP-2(62KD)和MMP-9(82KD)活性(70.46±13.04、14.67±6.13)明显高于包膜内浸润组(35.43±7.92、8.04±4.23)(P<0.001);而肿瘤直径≥1cm组和<1cm组血浆MMP-2(62KD)和MMP-9(82KD)活性(55.43±20.38vs59.30±20.77,10.85±5.72vs13.71±6.77)无显著差别(P>0.05),各组之间MMP-2(62KD+72KD)和MMP-9(82KD+92KD)活性无显著差别(P>0.05)。结论明胶酶的活化形式MMP-2(62KD)和MMP-9(82KD)和甲状腺乳头状癌转移与侵袭有关,和肿瘤的大小无关,可作为术前评估的重要指标。 Objective To study relationship between activity of matrix metalloproteinases (MMP-2 and-9) and invasion,metastasis of papillary thyroid carcinoma. Methods The serous activity of matrix metalloproteinases-2 and-9 of 74 patients with papillary thyroid carcinoma was measured by zymography. All of patients had a reformative radical cure operation. Results It was found that the serous activity of MMP -2 (62 KD) and MMP - 9 (82 KD) were apparently higher in patients with lymph node metastases (71.93±11.72, 15.50±6.06) and invasive carcinomas (70.46±13.04,14.67±6.13) than that in patients with no lymph node metastases (35.16±6.63,7.27±2.30) and invasive carcinomas (35.43±7.92,8.04±4.23), P< 0.001, respectively. There was no difference (P>0.05) in the serous activity of MMP - 2 (62 KD) and MMP -9(82 KD) of patients with different size tumor (55.43±20.38 to 59.30±20.77,10.85±5.72 to 13.71±6.77). There was also no difference in the serous activity of MMP-2(62 KD + 72 KD) and MMP-9 (82 KD + 92 KD) of patients with different size, invasion and metastases papillary thyroid carcinoma. Conclusion These results demonstrated a clear relationship between MMP - 2 (62 KD) and MMP - 9 (82 KD) activity and the invasion and metastsis of papillary thyroid carcinoma, but there was no relationship between the activity and the size of tumor. Preoperative measurement of serous activity of MMP - 2 (62 KD) and MMP - 9 (82 KD) is helpful in the diagnosis, evaluation and prediction of prognosis.
出处 《实用肿瘤学杂志》 CAS 2005年第2期87-90,共4页 Practical Oncology Journal
基金 温州医学院科研资助基金项目(2003A003)
  • 相关文献

参考文献9

  • 1F.奥斯伯 R.布伦特 R.E.金斯顿 等.颜子颖 王海林 译.精编分子生物学实验指南[M].北京:科学出版社,1998.366-370.
  • 2Turner HE, Nagy Z, Esiri MM, et al. Role of matrix metalloproteinase 9 in pituiary tumor behavior [J]. J Clin Endocrinol Metab, 2000;85(8):2931~2935.
  • 3SatoF, Shimada Y, Watanabe G, etal. Expression of vascular endothelial growth factor, matrix metalloproteinase - 9 and E- cadherin in the process of lymph node metastasis in oesophageal cancer [J]. Br J Cancer,1999;80(9):1366~1372.
  • 4Hedinger C, Williams ED, Sobin LH, et al. The WHO histological classification of thyroid tumors: a commentary on the second edition [J].Cacner, 1989;63:908~911.
  • 5Kleiner DE, Stetler- Stevenson WG. Quantitative zymography: detection of picogran quantities of gelatinases [J]. Anal biochem, 1994;218:325~325.
  • 6Parsons SL, Waston SA, Collins HM, et al. Gelatinase (MMP- 2 and MMP-9) expression in gastrointestinal malignancy [J]. Br J Cancer,1998;78(11):1496~1498.
  • 7Hofmnn A, LaueS, RostAK, etal. mRNA levels of memberane - typel matrix metalloproteinases (MT1 - MMP), MMP - 2 and MMP - 9 and of their inhibitors TIMP - 2 nd TIMP - 3 in normal thyrocytes and thyroid carcinboma cells lines [J]. Thyoid, 1998;8(3):203~214.
  • 8Nakamura H, Ueno H, Yamashita K, et al. Enhanced production and activation of progelatinase A mediated by membrane- type 1 matrix metallo-proteinase in human papillary thyroid carcinomas [J]. Cancer Research,1999;59(2):467~473.
  • 9张宏波,魏启幼.MMP-9,CD34在甲状腺乳头状癌中的表达[J].湖南医科大学学报,2003,28(4):427-428. 被引量:3

二级参考文献8

  • 1刘彤华 李维华.诊断病理学[M].北京:人民卫生出版社,1995.935.
  • 2Turner HE,Nagy Z,Esiri MM, et al. Role of matrix metalloproteinase 9 in pituitary tumor behavior[J]. J Clin Endocrinol Metab, 2000,85 ( 8 ) : 2931-2935.
  • 3Sato F, Shimada Y, Watanabe G, et al. expression of vascular endothelial growth factor, matrix metalloproteinase-9 and Ecadherin in the process of lymph node metastasis in oesophageal cancer[J]. Br J Cancer, 1999, 80(9):1366-1372.
  • 4Hedinger C,Williams ED,Sobin LH,et al. The WHO histological classification of thyroid tumors:a commentary on the second edition[J]. Cancer, 1989,63:908-911.
  • 5Weidner N, Semple JP, Welliam WR, et al. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma[J]. N Engl J Med,1991,324:1-8.
  • 6Kossakowska AE,Huchcroft SA,Urbanski SJ,et d. Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia,sporadic colorectal neopalsia,pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans[J]. Br J Cancer, 1996,73:1401-1408.
  • 7Wong NA, Willott J, Kendall M J, et al.measurement of vascularity as a diagnostic and prognostic tool for well differentiated thyroid turnouts:comparison of different methods of assessing vascular[J]. J Clin Pathol, 1999,52:593-597.
  • 8刘彤华.诊断病理学[M].北京:人民卫生出版社,1995.94-95.

共引文献23

同被引文献25

  • 1陈燕昌,陈大良.乳头状甲状腺癌基质金属蛋白酶-9的表达意义[J].肿瘤防治研究,2005,32(1):11-12. 被引量:7
  • 2江现强,刘志明,赫军,陆云飞.MMP-2在甲状腺癌中的表达及其临床意义[J].广西医科大学学报,2005,22(6):868-870. 被引量:3
  • 3Shindo M,Wu JC,Park E,et al.The importance of central compartment elective lymph node excision in the staging and treatment of papillary thyroid cancer[J].Arch Otolaryngol Head Neck Surg,2006,132(6):650-654.
  • 4Adams JC.Fascin protrusions in cell interactions[J].Trends Cardiovasc Med,2004,14(6):221-226.
  • 5Hashimoto Y,Skacel M,Adams JC.Roles of fascin in humancarcinoma motility and signaling:Prospects for a novelbiomarker[J].Int J Biochem Cell Biol,2005,37(9):1787-1804.
  • 6Bryan J,Kane RE.Separation and interaction of the major component of sea urchin actin gel[J].J Mol Biol,1978,125(2):207-224.
  • 7Jawhari AU,Buda A,Jenkins M,et al.Fascin,an actin-bunding protein,modulates colonic epithelial cell invasiveness and differentiation in vitro[J].Am J Pathol,2003,162(1):69-80.
  • 8Hashimoto Y,Shimada Y,Kawamura J,et al.The prognostic relevance of fascin expression in human gastric carcinoma[J].Oncology,2004,67(3-4):262-270.
  • 9Adams JC.Roles of fascin in cell adhesion and motility[J].Current Opinion in Cell Biology,2004,16(5):590-597.
  • 10Pelosi G,Pasini F,Fraggetta F,et al.Independent value of fascin immunoreactivity for predicting lymph node metastases in typical and atypical pulmonary carcinoids[J].Lung Cancer,2003,42(2):203-213.

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部